Description
DE-OBLIGATE FUNDS ON 626-C40053
Base award description: BLOOD CULTURE LEASE AND SUPPLIES
First action · last action
2019-10-01 · 2025-10-22
Transactions
14
First transaction's obligation
$56,048
Base + all options value (sum of deltas)
$223,767
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
541380 · TESTING LABORATORIES AND SERVICES
Modification chain · 14 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-10-01+$56,048= $56,048
- Mod P000032020-10-01+$56,048= $112,095
- Mod P000052021-10-01+$56,048= $168,143
- Mod P000062022-01-04-$41,243= $126,900
- Mod P000072022-10-01+$56,048= $182,948
- Mod P000082022-11-21-$15,440= $167,508
- Mod P000092023-10-01+$0= $167,508
- Mod P000102023-10-01+$56,048= $223,556
- Mod P000112024-06-26-$8,037= $215,519
- Mod P000122024-06-26-$1,058= $214,461
- Mod P000132024-10-01+$14,171= $228,632
- Mod P000142024-12-20+$0= $228,632
- Mod P000152025-06-27-$4,653= $223,979
- Mod P000162025-10-22-$212= $223,767
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-10-01 | +$56,048 | $56,048 | BLOOD CULTURE LEASE AND SUPPLIES |
| Mod P00003· EXERCISE AN OPTION | 2020-10-01 | +$56,048 | $112,095 | BLOOD CULTURE LEASE AND SUPPLIES |
| Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-10-01 | +$56,048 | $168,143 | BLOOD CULTURE LEASE AND SUPPLIES |
| Mod P00006· FUNDING ONLY ACTION | 2022-01-04 | −$41,243 | $126,900 | BLOOD CULTURE LEASE AND SUPPLIES |
| Mod P00007· EXERCISE AN OPTION | 2022-10-01 | +$56,048 | $182,948 | EXERCISE OPTION PERIOD 3 BLOOD CULTURE LEASE AND SUPPLIES |
| Mod P00008· OTHER ADMINISTRATIVE ACTION | 2022-11-21 | −$15,440 | $167,508 | EXERCISE OPTION PERIOD 3 BLOOD CULTURE LEASE AND SUPPLIES |
| Mod P00009· EXERCISE AN OPTION | 2023-10-01 | +$0 | $167,508 | EXERCISE OPTION PERIOD 3 BLOOD CULTURE LEASE AND SUPPLIES |
| Mod P00010· FUNDING ONLY ACTION | 2023-10-01 | +$56,048 | $223,556 | EXERCISE OPTION PERIOD 3 BLOOD CULTURE LEASE AND SUPPLIES |
| Mod P00011· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-06-26 | −$8,037 | $215,519 | DEOBLIGATE EXCESS FUNDS BLOOD CULTURE LEASE AND SUPPLIES |
| Mod P00012· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-06-26 | −$1,058 | $214,461 | QTY DECREASE ON CLIN 3004 BLOOD CULTURE LEASE AND SUPPLIES |
| Mod P00013· EXERCISE AN OPTION | 2024-10-01 | +$14,171 | $228,632 | EXERCISE 3 MONTHS UNDER 52.217-8 BLOOD CULTURE LEASE AND SUPPLIES |
| Mod P00014· EXERCISE AN OPTION | 2024-12-20 | +$0 | $228,632 | EXERCISE REMAINING 3 MONTHS UNDER 52.217-8 BLOOD CULTURE LEASE AND SUPPLIES |
| Mod P00015· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-06-27 | −$4,653 | $223,979 | DE-OBLIGATE FUNDS ON 626-C50082 |
| Mod P00016· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-10-22 | −$212 | $223,767 | DE-OBLIGATE FUNDS ON 626-C40053 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI DP4CNEMUF5F3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25926N0457 | NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $147,256 | FY2026 |
| 36C25926N0454 | NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $114,883 | FY2026 |
| 36C25726N0477 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $337,374 | FY2026 |
| 36C25726D0094 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C24526P0552 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $98,508 | FY2026 |
| 36C24126N0587 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $2,457 | FY2026 |
Other recipients under 6640 from 249-NETWORK CONTRACT OFFICE 9 (36C249) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24926P0515 | BRANCH MEDICAL LLC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $134,799 | FY2026 |
| 36C24926N0641 | DIASORIN INC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $172,138 | FY2026 |
| 36C24926P0473 | TERUMO BCT BIOTECHNOLOGIES, LLC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $16,420 | FY2026 |
| 36C24926P0421 | CREATIVE WASTE SOLUTIONS, INC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $35,433 | FY2026 |
| 36C24926P0425 | STRIPES GLOBAL, INC. | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $23,000 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24920C0059_3600_-NONE-_-NONE- · retrieved 2026-09-26.